Becton, Dickinson and Co. | BDX - L'Utile Operativo





L'Utile Operativo Cambiamento Data
Abbott USD 1.36B 775M 2026-09
Agilent USD 444M 45M 2026-06
Align Technology USD 193.04M 1.72M 2026-09
AngioDynamics USD -2.51M 5.41M 2025-09
Baxter International USD 314M 38M 2026-09
Becton, Dickinson and Co. USD 1.11B 357M 2026-09
Bio-Rad Laboratories USD 72.6M 38.5M 2026-06
Boston Scientific USD 1.01B 232M 2026-09
Cooper Companies USD 222M 253M 2026-06
Danaher USD 1.25B 118M 2026-09
Dentsply International USD 38M 46M 2026-09
Dexcom USD 318.3M 63M 2026-06
Edwards Lifesciences USD 542.7M 23.2M 2026-09
Globus Medical USD 178.23M 224.2M 2026-09
Insulet USD 189.8M 60.1M 2026-09
Integra LifeSciences USD 42.65M 1.36M 2026-09
Intuitive Surgical USD 1.05B 69.9M 2026-09
J&J USD 6.47B 1B 2026-09
Medtronic USD 1.84B 254M 2026-06
Solventum Corp USD 68M 113M 2026-09
Stryker USD 1.79B 687M 2026-06
Tandem Diabetes Care USD -2.37M 11.42M 2026-09
Teleflex USD -105.77M 178.84M 2026-09
Terumo JPY 89.48B 58.03B 2026-06
Thermo Fisher Scientific USD 2.46B 277M 2026-09
Zimmer Biomet Holdings USD 341.5M 3.2M 2026-09